The potential efficacy of GABAB antagonists in depression

被引：11
作者：
Alexander, Robert C. [1 ]
机构：
[1] Takeda Pharmaceut Int Co, 40 Landsdowne St, Cambridge, MA 02139 USA
来源：
CURRENT OPINION IN PHARMACOLOGY | 2017年 / 35卷
关键词：
RECEPTOR ANTAGONIST; FRONTAL-CORTEX; BINDING-SITES; ANTIDEPRESSANTS; RATS; ANXIETY; MODULATION; DISORDERS; BACLOFEN; DRUGS;
D O I：
10.1016/j.coph.2017.07.009
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Evidence for the potential utility of GABAB antagonists has been assembled from a variety of sources, including clinical experience with the GABAB agonist baclofen, murine genetic GABAB knock-outs, rodent studies of GABAB receptor expression and function following treatment with antidepressant therapies, animal models of depression, and some functional and post mortem data from human subjects. Definitive testing of GABAB antagonists in depression, however, still awaits the development of potent, selective and brain-penetrant compounds for human testing.
引用
收藏
页码：101 / 104
页数：4
相关论文
共 29 条
[21]   GABAB RECEPTORS ARE UP-REGULATED BY CHRONIC TREATMENT WITH LITHIUM OR CARBAMAZEPINE - GABA HYPOTHESIS OF AFFECTIVE-DISORDERS [J].
MOTOHASHI, N ;
IKAWA, K ;
KARIYA, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (01) :95-99
[22]   The GABAA receptor antagonist CGP36742 improves learned helplessness in rats [J].
Nakagawa, Y ;
Sasaki, A ;
Takashima, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 381 (01) :1-7
[23]   Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents [J].
Nowak, G. ;
Partyka, A. ;
Palucha, A. ;
Szewczyk, B. ;
Wieronska, J. M. ;
Dybala, M. ;
Metz, M. ;
Librowski, T. ;
Froestl, W. ;
Papp, M. ;
Pilc, A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (05) :581-590
[24]   LACK OF BENEFICIAL-EFFECTS OF L-BACLOFEN IN AFFECTIVE-DISORDER [J].
POST, RM ;
KETTER, TA ;
JOFFE, RT ;
KRAMLINGER, KL .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1991, 6 (04) :197-207
[25]   Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors [J].
Sanacora, G ;
Mason, GF ;
Rothman, DL ;
Krystal, JH .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04) :663-665
[26]   Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus [J].
Sands, SA ;
Reisman, SA ;
Enna, SJ .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (08) :1489-1495
[27]   PARALLEL CHANGES IN THE SENSITIVITY OF GAMMA-AMINOBUTYRIC ACID AND NORADRENERGIC RECEPTORS FOLLOWING CHRONIC ADMINISTRATION OF ANTIDEPRESSANT AND GABAERGIC DRUGS - A POSSIBLE ROLE IN AFFECTIVE-DISORDERS [J].
SUZDAK, PD ;
GIANUTSOS, G .
NEUROPHARMACOLOGY, 1985, 24 (03) :217-222
[28]  
SZEKELY AM, 1987, J PHARMACOL EXP THER, V243, P155
[29]   Synthesis and in vivo evaluation of [11C]CGP62349, a new GABAB receptor antagonist [J].
Todde, S ;
Moresco, RM ;
Fröstl, W ;
Stampf, P ;
Matarrese, M ;
Carpinelli, A ;
Magni, F ;
Kienle, MG ;
Fazio, F .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (06) :565-569
123